StockData
Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI) stock

MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.28−0.12 (-1.62%)

Close on Nov 17, 2026Market cap $1.89BP/E –Yield –

Maravai LifeSciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Maravai LifeSciences's price to book ratio was 5.5× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 0.9× to 31.9×, with a median of 2.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.5×+3.6
2025Dec 31, 20251.9×−0.2
2024Dec 31, 20242.1×+0.1
2023Dec 29, 20232.1×−4.3
2022Dec 30, 20226.4×–

More Maravai LifeSciences figures

See a number that looks wrong?